Eden Research (LON:EDEN) Shares Down 3.3% – What’s Next?

Eden Research plc (LON:EDEN)’s share price fell 3.3% during trading on Saturday . The stock traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares were traded during trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Performance

The stock has a market cap of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.42 and a current ratio of 3.80. The company’s 50 day simple moving average is GBX 3.88 and its 200 day simple moving average is GBX 3.95.

Insider Buying and Selling at Eden Research

In other Eden Research news, insider Alexander John Abrey acquired 540,540 shares of the stock in a transaction dated Tuesday, January 28th. The shares were bought at an average price of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,317.25). Also, insider Lykele van der Broek acquired 256,000 shares of the stock in a transaction dated Thursday, February 6th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,937.46). 14.02% of the stock is owned by corporate insiders.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.